Log In
Print this Print this

epitinib (HMPL-813)

  Manage Alerts
Collapse Summary General Information
Company Hutchison China MediTech Ltd.
DescriptionEpidermal growth factor receptor (EGFR) inhibitor
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionEpidermal growth factor (EGF) receptor inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationBrain cancer
Indication DetailsTreat brain metastases from non-small cell lung cancer (NSCLC); Treat glioblastoma multiforme (GBM)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today